Carbon Monoxide Diffusion Capacity: How Low Can You Go for Hematopoietic Cell Transplantation Eligibility?

Biology of Blood and Marrow Transplantation

Volumn 15, Issue 4, 2009, Pages 447-453

  Chien, Jason W ^a,b   Sullivan, Keith M ^c  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Diffusion capacity; DLCO; Nonrelapse mortality; Stem cell transplant

Indexed keywords

CARBON MONOXIDE;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CONTROLLED STUDY; FEMALE; HUMAN; LUNG DIFFUSION CAPACITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRACTICE GUIDELINE; RESPIRATORY FAILURE; RISK ASSESSMENT; SCORING SYSTEM;

ADULT; CARBON MONOXIDE; DIFFUSION; FEMALE; GUIDELINES AS TOPIC; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; RESPIRATORY INSUFFICIENCY; RETROSPECTIVE STUDIES; RISK FACTORS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 61749083453     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2008.12.509     Document Type: Article

References (28)

1. Chien J.W., Madtes D.K., and Clark J.G. Pulmonary function testing prior to hematopoietic stem cell transplantation. Bone Marrow Transplant 35 (2005) 429-435
2. Ho V.T., Weller E., Lee S.J., et al. Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 7 (2001) 223-229
3. Horak D.A., Schmidt G.M., Zaia J.A., et al. Pretransplant pulmonary function predicts cytomegalovirus-associated interstitial pneumonia following bone marrow transplantation. Chest 102 (1992) 1484-1490
4. Ghalie R., Szidon J.P., Thompson L., et al. Evaluation of pulmonary complications after bone marrow transplantation: the role of pretransplant pulmonary function tests. Bone Marrow Transplant 10 (1992) 359-365
5. Badier M., Guillot C., Delpierre S., et al. Pulmonary function changes 100 days and one year after bone marrow transplantation. Bone Marrow Transplant 12 (1993) 457-461
6. Chien J.W., Martin P.J., Gooley T.A., et al. Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation. Am J Respir Crit Care Med 168 (2003) 208-214
7. Goldberg S.L., Klumpp T.R., Magdalinski A.J., et al. Value of the pretransplant evaluation in predicting toxic day-100 mortality among blood stem cell and bone marrow transplant recipients. J Clin Oncol 16 (1998) 3796-3802
8. Crawford S.W., and Fisher L. Predictive value of pulmonary function tests before marrow transplantation. Chest 101 (1992) 1257-1264
9. Matute-Bello G., McDonald G.D., Hinds M.S., et al. Association of pulmonary function testing abnormalities and severe veno-occlusive disease of the liver after marrow transplantation. Bone Marrow Transplant 21 (1998) 1125-1130
10. Keller C, Chatchada K. Evaluating adult patients prior to hematopoietic cell transplant. Available from: http://www.marrow.org. Accessed February 10, 2009.
11. Parimon T., Au D.H., Martin P.J., et al. A risk score for mortality after allogeneic hematopoietic cell transplantation. Ann Intern Med 144 (2006) 407-414
12. Parimon T., Madtes D.K., Au D.H., et al. Pretransplant lung function, respiratory failure, and mortality after stem cell transplantation. Am J Respir Crit Care Med 172 (2005) 384-390
13. Sorror M.L., Giralt S., Sandmaier B.M., et al. Hematopoietic cell transplantation- specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences. Blood 110 (2007) 4606-4613
14. Sorror M.L., Maris M.B., Storb R., et al. Hematopoietic cell transplantation (HCT)- specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 106 (2005) 2912-2919
15. Sorror M.L., Sandmaier B.M., Storer B.E., et al. Comorbidity and disease status-based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation. J Clin Oncol 25 (2007) 4246-4254
16. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 144 (1991) 1202-1218
17. American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor): recommendations for a standard technique, 1995 update. Am J Respir Crit Care Med 152 (1995) 2185-2198
18. Crapo R.O., Morris A.H., and Gardner R.M. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 123 (1981) 659-664
19. Crapo R.O., and Morris A.H. Standardized single-breath normal values for carbon monoxide diffusing capacity. Am Rev RespirDis 123 (1981) 185-189
20. Blakemore W.S., Forster R.E., Morton J.W., et al. A standardized breath-holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide. J Clin Invest 36 (1957) 1-17
21. Crapo R.O., and Forster II R.E. Carbon monoxide diffusing capacity. Clin Chest Med 10 (1989) 187-198
22. Cotes J.E., Dabbs J.M., Elwood P.C., et al. Iron-deficiency anaemia: its effect on transfer factor for the lung (diffusion capacity) and ventilation and cardiac frequency during sub-maximal exercise. Clin Sci 42 (1972) 325-335
23. Punjabi N.M., Shade D., Patel A.M., et al. Measurement variability in single-breath diffusing capacity of the lung. Chest 123 (2003) 1082-1089
24. Yamaguchi K., Mori M., Kawai A., et al. Inhomogeneities of ventilation and the diffusing capacity to perfusion in various chronic lung diseases. Am J Respir Crit Care Med 156 (1997) 86-93
25. Stam H., Splinter T.A., and Versprille A. Evaluation of diffusing capacity in patients with a restrictive lung disease. Chest 117 (2000) 752-757
26. Johnson D.C. Importance of adjusting carbon monoxide diffusing capacity (DLCO) and carbon monoxide transfer coefficient (KCO) for alveolar volume. Respir Med 94 (2000) 28-37
27. Kangalee K.M., and Abboud R.T. Interlaboratory and intralaboratory variability in pulmonary function testing: a 13-year study using a normal biologic control. Chest 101 (1992) 88-92
28. Mushtaq M., Hayton R., Watts T., et al. An audit of pulmonary function laboratories in the West Midlands. Respir Med 89 (1995) 263-270